In another study, treatment with andrographolide suppressed cardiac inflammation via nuclear factor-κB (NF-κB) and reduced both cardiac fibrosis and cardiac hypertrophy in streptozotocin-induced diabetic mice (Liang et al., 2018). Here, NFKB1 is linked to cardiac hypertrophy.